Advanced SearchSearch Tips
Glycogen synthase kinase 3β in Toll-like receptor signaling
facebook(new window)  Pirnt(new window) E-mail(new window) Excel Download
  • Journal title : BMB Reports
  • Volume 49, Issue 6,  2016, pp.305-310
  • Publisher : Korean Society for Biochemistry and Molecular Biology
  • DOI : 10.5483/BMBRep.2016.49.6.059
 Title & Authors
Glycogen synthase kinase 3β in Toll-like receptor signaling
Ko, Ryeojin; Lee, Soo Young;
  PDF(new window)
Toll-like receptors (TLRs) play a critical role in the innate immune response against pathogens. Each TLR recognizes specific pathogen-associated molecular patterns, after which they activate the adaptor protein MyD88 or TRIF-assembled signaling complex to produce immune mediators, including inflammatory cytokines and type I IFNs. Although the activation of TLR is important for host defense, its uncontrolled activation can damage the host. During the past decade, numerous studies have demonstrated that GSK3β is a key regulator of inflammatory cytokine production in MyD88-mediated TLR signaling via TLR2 and TLR4. Recently, GSK3β has also been implicated in the TRIF-dependent signaling pathway via TLR3. In this review, we describe current advances on the regulatory role of GSK3β in immune responses associated with various TLRs. A better understanding of the role of GSK3β in TLR signaling might lead to more effective anti-inflammatory interventions.
Glycogen synthase kinase 3β (GSK3β);Inflammatory cytokines;Toll-like receptor (TLR);Type I interferons (IFNs);
 Cited by
Beauvericin, a cyclic peptide, inhibits inflammatory responses in macrophages by inhibiting the NF-κB pathway, The Korean Journal of Physiology & Pharmacology, 2017, 21, 4, 449  crossref(new windwow)
Medzhitov R and Janeway CA Jr (1997) Innate immunity: the virtues of a nonclonal system of recognition. Cell 91, 295-298 crossref(new window)

Akira S and Takeda K (2004) Toll-like receptor signalling. Nat Rev Immunol 4, 499-511 crossref(new window)

Akira S, Uematsu S and Takeuchi O (2006) Pathogen recognition and innate immunity. Cell 124, 783-801 crossref(new window)

Kawai T and Akira S (2010) The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors. Nat Immunol 11, 373-384 crossref(new window)

Kawagoe T, Sato S and Matsushita K et al (2008) Sequential control of Toll-like receptor-dependent responses by IRAK1 and IRAK2. Nat Immunol 9, 684-691 crossref(new window)

Bhoj VG and Chen ZJ (2009) Ubiquitylation in innate and adaptive immunity. Nature 458, 430-437 crossref(new window)

Oganesyan G, Saha SK and Guo B et al (2006) Critical role of TRAF3 in the Toll-like receptor-dependent and -independent antiviral response. Nature 439, 208-211 crossref(new window)

Meylan E, Burns K and Hofmann K et al (2004) RIP1 is an essential mediator of Toll-like receptor 3-induced NF-kappa B activation. Nat Immunol 5, 503-507 crossref(new window)

Embi N, Rylatt DB and Cohen P (1980) Glycogen synthase kinase-3 from rabbit skeletal muscle. Separation from cyclic-AMP-dependent protein kinase and phosphorylase kinase. Eur J Biochem 107, 519-527 crossref(new window)

Woodgett JR (1990) Molecular cloning and expression of glycogen synthase kinase-3/factor A. EMBO J 9, 2431-2438

Force T and Woodgett JR (2009) Unique and overlapping functions of GSK-3 isoforms in cell differentiation and proliferation and cardiovascular development. J Biol Chem 284, 9643-9647 crossref(new window)

Doble BW and Woodgett JR (2003) GSK-3: tricks of the trade for a multi-tasking kinase. J Cell Sci 116, 1175-1186 crossref(new window)

Jope RS and Johnson GV (2004) The glamour and gloom of glycogen synthase kinase-3. Trends Biochem Sci 29, 95-102 crossref(new window)

Rayasam GV, Tulasi VK, Sodhi R, Davis JA and Ray A (2009) Glycogen synthase kinase 3: more than a namesake. Br J Pharmacol 156, 885-898 crossref(new window)

Cross DA, Watt PW and Shaw M et al (1997) Insulin activates protein kinase B, inhibits glycogen synthase kinase-3 and activates glycogen synthase by rapamycin-insensitive pathways in skeletal muscle and adipose tissue. FEBS Lett 406, 211-215 crossref(new window)

Bax B, Carter PS and Lewis C et al (2001) The structure of phosphorylated GSK-3beta complexed with a peptide, FRATtide, that inhibits beta-catenin phosphorylation. Structure 9, 1143-1152 crossref(new window)

Beurel E, Michalek SM and Jope RS (2010) Innate and adaptive immune responses regulated by glycogen synthase kinase-3 (GSK3). Trends Immunol 31, 24-31 crossref(new window)

Wang H, Brown J and Martin M (2011) Glycogen synthase kinase 3: a point of convergence for the host inflammatory response. Cytokine 53, 130-140 crossref(new window)

Wang H, Kumar A, Lamont RJ and Scott DA (2014) GSK3β and the control of infectious bacterial diseases. Trends Microbiol 22, 208-217 crossref(new window)

Ko R, Park JH, Ha H, Choi Y and Lee SY (2015) Glycogen synthase kinase 3β ubiquitination by TRAF6 regulates TLR3-mediated pro-inflammatory cytokine production. Nat Commun 6, 6765 crossref(new window)

Medzhitov R, Preston-Hurlburt P and Janeway CA Jr (1997) A human homologue of the Drosophila Toll protein signals activation of adaptive immunity. Nature 388, 394-397 crossref(new window)

Poltorak A, He X and Smirnova I (1998) Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science 282, 2085-2088 crossref(new window)

Arbibe L, Mira JP and Teusch N et al (2000) Toll-like receptor 2-mediated NF-kappa B activation requires a Rac1-dependent pathway. Nat Immunol 1, 533-540 crossref(new window)

Guha M and Mackman N (2002) The phosphatidylinositol 3-kinase-Akt pathway limits lipopolysaccharide activation of signaling pathways and expression of inflammatory mediators in human monocytic cells. J Biol Chem 277, 32124-32132 crossref(new window)

Martin M, Rehani K, Jope RS and Michalek SM (2005) Toll-like receptor-mediated cytokine production is differentially regulated by glycogen synthase kinase 3. Nat Immunol 6, 777-784 crossref(new window)

Wang H, Brown J and Gu Z et al (2011) Convergence of the mammalian target of rapamycin complex 1- and glycogen synthase kinase 3-β-signaling pathways regulates the innate inflammatory response. J Immunol 186, 5217-5226 crossref(new window)

Nandan D, Camargo de Oliveira C and Moeenrezakhanlou A et al (2012) Myeloid cell IL-10 production in response to leishmania involves inactivation of glycogen synthase kinase-3β downstream of phosphatidylinositol-3 kinase. J Immunol 188, 367-378 crossref(new window)

Paul J, Naskar K, Chowdhury S, Chakraborti T and De T (2014) TLR mediated GSK3β activation suppresses CREB mediated IL-10 production to induce a protective immune response against murine visceral leishmaniasis. Biochimie 107, 235-246 crossref(new window)

Rehani K, Wang H, Garcia CA, Kinane DF and Martin M (2009) Toll-like receptor-mediated production of IL-1Ra is negatively regulated by GSK3 via the MAPK ERK1/2. J Immunol 182, 547-553 crossref(new window)

Beurel E and Jope RS (2009) GSK3 promotes the synergistic action of interferon-gamma on lipopolysaccharide-induced IL-6 production in RAW264.7 cells. Cell Signal 21, 978-985 crossref(new window)

Noh KT, Park YM, Cho SG and Choi EJ (2011) GSK-3β-induced ASK1 stabilization is crucial in LPS-induced endotoxin shock. Exp Cell Res 317, 1663-1668 crossref(new window)

Wang H, Garcia CA and Rehani K et al (2008) IFN-beta production by TLR4-stimulated innate immune cells is negatively regulated by GSK3-beta. J Immunol 181, 6797-6802 crossref(new window)

Ozinsky A, Underhill DM and Fontenot JD et al (2000) The repertoire for pattern recognition of pathogens by the innate immune system is defined by cooperation between Toll-like receptors. Proc Natl Acad Sci U S A 97, 13766-13771 crossref(new window)

Farhat K, Riekenberg S and Heine H (2008) Heterodimerization of TLR2 with TLR1 or TLR6 expands the ligand spectrum but does not lead to differential signaling. J Leukoc Biol 83, 692-701 crossref(new window)

Borrello S, Nicolò C, Delogu G, Pandolfi F and Ria F (2011) TLR2: a crossroads between infections and autoimmunity? Int J Immunopathol Pharmacol 24, 549-556 crossref(new window)

Hu X, Paik PK and Chen J et al (2006) IFN-gamma suppresses IL-10 production and synergizes with TLR2 by regulating GSK3 and CREB/AP-1 proteins. Immunity 24, 563-574 crossref(new window)

Zhang P, Katz J and Michalek SM (2009) Glycogen synthase kinase-3beta (GSK3beta) inhibition suppresses the inflammatory response to Francisella infection and protects against tularemia in mice. Mol Immunol 46, 677-687 crossref(new window)

Cheng YL, Wang CY and Huang WC et al (2009) Staphylococcus aureus induces microglial inflammation via a glycogen synthase kinase 3beta-regulated pathway. Infect Immun 77, 4002-4008 crossref(new window)

Cortés-Vieyra R, Silva-García O and Oviedo-Boyso et al (2015) The Glycogen Synthase Kinase 3α and β Isoforms Differentially Regulates Interleukin-12p40 Expression in Endothelial Cells Stimulated with Peptidoglycan from Staphylococcus aureus. PLoS One 10, e0132867 crossref(new window)

Alexopoulou L, Holt AC, Medzhitov R and Flavell RA (2001) Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3. Nature 413, 732-738 crossref(new window)

Matsumoto M and Seya T (2008) TLR3: interferon induction by double-stranded RNA including poly(I:C). Adv Drug Deliv Rev 60, 805-812 crossref(new window)

Perales-Linares R and Navas-Martin S (2013) Toll-like receptor 3 in viral pathogenesis: friend or foe? Immunology 140, 153-167 crossref(new window)

Yamamoto M, Sato S and Hemmi H et al (2003) Role of adaptor TRIF in the MyD88-independent toll-like receptor signaling pathway. Science 301, 640-643 crossref(new window)

Fitzgerald KA, McWhirter SM and Faia KL et al (2003) IKKepsilon and TBK1 are essential components of the IRF3 signaling pathway. Nat Immunol 4, 491-496 crossref(new window)

Hiscott J (2007) Triggering the innate antiviral response through IRF-3 activation. J Biol Chem 282, 15325-15329 crossref(new window)

Sato S, Sugiyama M and Yamamoto M et al (2003) Toll/IL-1 receptor domain-containing adaptor inducing IFN-beta (TRIF) associates with TNF receptor-associated factor 6 and TANK-binding kinase 1, and activates two distinct transcription factors, NF-kappa B and IFN-regulatory factor-3, in the Toll-like receptor signaling. J Immunol 171, 4304-4310 crossref(new window)

Meylan E, Burns K and Hofmann K et al (2004) RIP1 is an essential mediator of Toll-like receptor 3-induced NF-kappa B activation. Nat Immunol 5, 503-507 crossref(new window)

Kawai T and Akira S (2009) The roles of TLRs, RLRs and NLRs in pathogen recognition. Int Immunol 21, 317-337 crossref(new window)

Chattopadhyay S and Sen GC (2014) dsRNA-activation of TLR3 and RLR signaling: gene induction-dependent and independent effects. J Interferon Cytokine Res 34, 427-436 crossref(new window)

Lei CQ, Zhong B and Zhang Y et al (2010) Glycogen synthase kinase 3β regulates IRF3 transcription factor-mediated antiviral response via activation of the kinase TBK1. Immunity 33, 878-889 crossref(new window)